# A Clinical Study on the Treatment of Metastatic Colorectal Cancer at the Second-line or Beyond.

Source: https://onco.cc/trials/nct07395063/  
OnCo record `nct07395063` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of camrelizumab in colorectal cancer, run by The Fourth Affiliated Hospital of Zhejiang University School of Medicine, not yet recruiting.

## Summary

A Clinical Study on the Treatment of Metastatic Colorectal Cancer at the Second-line or Beyond. is a phase 2, interventional study registered as NCT07395063 by The Fourth Affiliated Hospital of Zhejiang University School of Medicine, with a registry enrolment figure of 68 participants, started 2026-02-01 and due to reach its primary completion in 2029-02-01. Interventions recorded: Irinotecan liposome combined with capecitabine, bevacizumab and camrelizumab. Conditions listed: Metastatic Colorectal Cancer (CRC). Primary outcome: Progression-free survival (PFS）. Colorectal eligibility wording from the registry: "* Patients pathologically diagnosed with colorectal cancer;". No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT07395063
- Phase: 2
- Setting: A Single-arm, Open-label Clinical Study of Irinotecan Liposome Combined With Capecitabine, Bevacizumab and Camrelizumab as Second-line or Higher Treatment for Patients With Metastatic Colorectal Cancer
- Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- Enrolled: 68

## Sources

- ClinicalTrials.gov NCT07395063: https://clinicaltrials.gov/study/NCT07395063

## Connected records

- cancers: [Colon cancer (adenocarcinoma of the colon)](https://onco.cc/cancers/colon-cancer/), [Rectal cancer](https://onco.cc/cancers/rectal-cancer/)
- technologies: [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/)
- drugs: [Camrelizumab](https://onco.cc/drugs/camrelizumab/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07395063.json